ASND vs. KLAC
ASND (Ascendis Pharma A/S) and KLAC (KLA Corporation) are both stocks. ASND operates in Biotechnology (Healthcare), while KLAC operates in Semiconductor Equipment & Materials (Technology). Over the past 10 years, ASND returned 33.14%/yr vs 45.08%/yr for KLAC. At a 0.20 correlation, their price movements are largely independent.
Performance
ASND vs. KLAC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ASND achieves a 2.26% return, which is significantly lower than KLAC's 110.02% return. Over the past 10 years, ASND has underperformed KLAC with an annualized return of 33.14%, while KLAC has yielded a comparatively higher 45.08% annualized return.
ASND
- 1D
- 1.14%
- 1M
- -10.48%
- YTD
- 2.26%
- 6M
- -1.07%
- 1Y
- 27.58%
- 3Y*
- 32.88%
- 5Y*
- 10.86%
- 10Y*
- 33.14%
KLAC
- 1D
- 5.55%
- 1M
- 37.79%
- YTD
- 110.02%
- 6M
- 113.75%
- 1Y
- 192.78%
- 3Y*
- 75.88%
- 5Y*
- 52.93%
- 10Y*
- 45.08%
ASND vs. KLAC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ASND Ascendis Pharma A/S | 2.26% | 54.89% | 9.31% | 3.13% | -9.22% | -19.34% | 19.88% | 122.06% | 56.39% | 97.92% |
KLAC KLA Corporation | 110.02% | 94.48% | 9.36% | 56.05% | -11.20% | 68.05% | 47.94% | 103.99% | -12.49% | 36.80% |
Correlation
The correlation between ASND and KLAC is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jan 28, 2015 | 0.20 |
The correlation between ASND and KLAC shifts across timeframes, from -0.01 (1 year) to 0.20 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
ASND:
$14.07B
KLAC:
$33.62B
ASND:
€8.08
KLAC:
$35.29
ASND:
23.32
KLAC:
7.21
ASND:
0.11
KLAC:
0.27
ASND:
13.62
KLAC:
2.57
ASND:
24.89
KLAC:
5.77
ASND:
€867.51M
KLAC:
$13.10B
ASND:
€764.89M
KLAC:
$8.09B
ASND:
-€6.94M
KLAC:
$5.77B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ASND vs. KLAC — Risk / Return Rank
ASND
KLAC
ASND vs. KLAC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and KLA Corporation (KLAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ASND | KLAC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.18 | ||
| Sortino ratioReturn per unit of downside risk | -2.46 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.54 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | 1.59 | 8.66 | -7.07 |
| Martin ratioReturn relative to average drawdown | 4.87 | 27.54 | -22.67 |
Loading charts...
Drawdowns
ASND vs. KLAC - Drawdown Comparison
The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum KLAC drawdown of -83.74%. Use the drawdown chart below to compare losses from any high point for ASND and KLAC.
Loading charts...
Drawdown Indicators
| ASND | KLAC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.72% | -83.74% | +22.02% |
Max Drawdown (1Y)Largest decline over 1 year | -17.62% | -22.41% | +4.79% |
Max Drawdown (3Y)Largest decline over 3 years | -29.15% | -34.95% | +5.80% |
Max Drawdown (5Y)Largest decline over 5 years | -60.46% | -40.28% | -20.18% |
Max Drawdown (10Y)Largest decline over 10 years | -61.72% | -40.28% | -21.44% |
Current DrawdownCurrent decline from peak | -12.72% | 0.00% | -12.72% |
Average DrawdownAverage peak-to-trough decline | -18.90% | -29.32% | +10.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.72% | 7.03% | -1.31% |
Volatility
ASND vs. KLAC - Volatility Comparison
The current volatility for Ascendis Pharma A/S (ASND) is 13.12%, while KLA Corporation (KLAC) has a volatility of 22.17%. This indicates that ASND experiences smaller price fluctuations and is considered to be less risky than KLAC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ASND | KLAC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.12% | 22.17% | -9.05% |
Volatility (6M)Calculated over the trailing 6-month period | 29.45% | 42.02% | -12.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.26% | 49.38% | -12.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.65% | 43.88% | +4.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 51.09% | 41.86% | +9.23% |
Dividends
ASND vs. KLAC - Dividend Comparison
ASND has not paid dividends to shareholders, while KLAC's dividend yield for the trailing twelve months is around 0.31%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASND Ascendis Pharma A/S | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
KLAC KLA Corporation | 0.31% | 0.61% | 0.96% | 0.92% | 1.25% | 0.91% | 1.35% | 1.74% | 3.17% | 2.15% | 2.67% | 2.94% |
Financials
ASND vs. KLAC - Financials Comparison
This section allows you to compare key financial metrics between Ascendis Pharma A/S and KLA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ASND and KLAC have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KLAC has higher volatility (22.17%) compared to ASND (13.12%). In terms of maximum drawdown, ASND dropped -61.72% vs KLAC's -83.74%.
KLAC currently has the higher Sharpe Ratio (3.93 vs 0.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ASND and KLAC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer